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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S87Purpose: Osteoarthritis is degenerative joint disease that leads to
permanent joint damage and is a multi-factorial complex disease. It is
well established that in OA cartilage and synovium that some of the
metalloproteinases (MMP) are over expressed including MMP- 2, 9 and
13 and Tissue inhibitors of Matrix metalloproteinases (TIMP) are down
regulated. There is currently great interest in the ﬁeld of OA to identify
biomarkers that provide a method for earlier diagnosis and identify
patients at higher risk for disease progression. This study was designed
to test the hypothesis that plasma levels of gelatinase(s) MMP-2 and 9
predict knee OA severity and progression based on radiographic
ﬁndings.
Methods: 150 Symptomatic knee OA (SKOA) patients (mean age 63.09 
10.3, mean BMI 26.5  3.6) fulﬁlling ACR criteria for knee OA were
recruited as part of an NIH-funded 24 month prospective study. These
patients were followed longitudinally for 24 months, x-ray were taken at
visit 0 and 24 months. The blood samples were collected at baseline and
every 6 months. Standardized semi-ﬂexed radiographs were scored for
overall Kellgren and Lawrence (KL) grade, osteophytes, joint space width
(JSW) and subchondral sclerosis by the same radiologist. Plasma samples
from visit 18 month of 128 OA patients (37% male) were assayed for
gelatinase(s) MMP-2 and 9 using the highly sensitive Erenna Immunoassay
system (Singulex, Inc). For radiographic severity, biomarker were evalu-
ated between KL scores of 1, 2 with those with scores of 3, 4. Progression of
knee OA was deﬁned as a change between baseline and 24 month visit in
narrowest joint space width (JSW) in signal knee.
Results: The mean plasma MMP2 and 9 (pro and total) levels were 83.0 
63.05 ng/ml, 30.7  32.64 and 455.9  290.09 (all ng/mL), respectively.
Only total MMP-9 positively correlated with KL score both at baseline
(r¼0.220; p<0.036) and 24 (r¼0.249; p<0.015) month. MMP-2 or
proMMP9 levels did not correlate with either radiographic marker. We
further analyzed association of tMMP9 level with radiographic severity
and progression by JSN as deﬁned in the methods. tMMP9 correlated with
radiographic severity (p<0.061) at baseline, and with progressive joint
space narrowing (r¼ 0.228; p<0.015). However, we did not observe
signiﬁcant association between tMMP9 and delta KL score in this 24month
study.
Conclusions: These ﬁndings indicate that elevated levels of total gelati-
nase -9 (tMMP9) are associated with radiographic severity of SKOA and
predict an increased risk of progressive joint space narrowing (JSN). These
observations, which suggest that tMMP9 is a candidate prognostic
biomarker, merit further validation in larger cohort of SKOA patients.160
STRUCTURAL PROGRESSION OF ANKYLOSING SPONDYLITIS IS
ASSOCIATED WITH ELEVATION IN TWO NOVEL, INFLAMMATORY
BIOMARKERS; MATRIX METALLOPROTEINASE AND CATHEPSIN-
DERIVED CRP
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Purpose: Ankylosing Spondylitis (AS) is a chronic inﬂammatory disease,
however current inﬂammatory biomarkers, such as CRP, have insufﬁcient
sensitivity and speciﬁcity to be broadly accepted in the diagnosis and
prognosis of this disease. We hypothesized, that quantiﬁcation of inﬂam-
mation markers derived from the affected tissue might have improved
clinical utility compared to the systemic markers, and we therefore
developed two novel biomarker assays detecting MMP and Cathepsin-
derived CRP. Both CRP-MMP and CRP-CAT has been reported to be elevated
in AS compared to controls (Skjøt-Arkil et al., in print), whereas full-length
CRP was not.
The purpose of the present study was to determine, in a larger, second
cohort of patients with AS, the clinical utility of CRP-MMP and CRP-CAT
including (1) diagnostic sensitivity & speciﬁcity, (2) association with long-
term radiological changes in the spine (modiﬁed Stoke AS Spinal Score
(mSASSS)), and (3) sensitivity to anti-TNF treatment.
Methods: Cohort 1; Serum samples (n¼124) obtained from patients
diagnosed with AS was available for this study. Mean duration of diseasewas 18,0+11,4 years (mean+SD) and they had received 2.3+9.7 months of
anti-TNF treatment before study entry.
Within this cohort, samples from 16 AS patients with structural progres-
sion over two years and 29 without were selected for evaluation of the
prognostic value of the marker set (sub-cohort 1A). Structural progression
was achieved in subjects having a baseline mSASSS of at least 10 units
increasing with at least 5 units over two years, and simultaneously the
occurrence of at least one new syndesmophyte.
Sub-cohort 1B contained samples from 53 AS patients from cohort 1, and
these originated from patients who subsequently received anti-TNF
treatment for three months and was then re-tested with the marker panel.
Finally, we included serum samples (n¼40) from healthy subjects as
additional controls (Cohort 2).
Serum samples were tested for CRP-MMP and CRP-CAT (Nordic Bioscience,
Denmark).
Results: For baseline evaluations, data from cohort 1 and 2 were used.
CRP-MMP and CRP-CAT were both elevated in AS compared to controls;
9.84+4.40 ng/ml (mean+SD) vs 4.82+1.49 ng/ml (p<0.05), respectively, for
CRP-MMP; and 299.6+137.6 ng/ml vs 178.6+54.03 ng/ml (p<0.05), for CRP-
MMP. Diagnostic capability was assessed by ROC analysis, and AUC was
0.94 (p<0.0001) and 0.85 (p<0.0001) for CRP-MMP and CRP-CAT,
respectively.
In AS patients with structural progression over two years (sub-cohort 1A),
CRP-MMP and CRP-CAT were signiﬁcantly elevated at baseline compared
to non-progressors, whereas hsCRP was not; 9.2+3.1 ng/ml vs 7.6+2.2 ng/
ml for CRP-MMP, 276+108 ng/ml vs 218+67 ng/ml for CRP-CAT, and
21.9+25.6 ng/ml vs 12.7+21.5 ng/ml for hsCRP, respectively.
Finally, both CRP-related markers decreased signiﬁcantly after short term
(2-3 months) of anti-TNF treatment (sub-cohort 1B).
Conclusions: In a second, much larger cohort of AS patients, we have
conﬁrmed the original observation, that MMP and Cathepsin-derived
fragments of CRP, i.e. CRP-MMP and CRP-CAT, both are signiﬁcantly
elevated in AS patients. Importantly, both markers, but not hsCRP, were
signiﬁcantly elevated at baseline in patients having structural progression
deﬁned by a composite index including mSASSS and syndesmophyte
quantiﬁcation.
Further studies are needed to determine if the suggested association of the
two CRP-fragments with structural deterioration of AS reﬂects a metabolic
link to pathological processes in the spine.
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ADIPOKINES AND (VERY) EARLY-STAGE OSTEOARTHRITIS BURDEN AND
PROGRESSION OF KNEE AND HIP: DATA FROM CHECK
W.E. van Spil, N.W. Jansen, S.C. Mastbergen, J.W. Bijlsma, F.P. Lafeber. Univ.
Med. Ctr. Utrecht, Utrecht, Netherlands
Purpose: To investigate the potential relevance of adipokines in the
development and/or progression of (very) early knee and hip osteoarthritis
(OA).
Methods: Adipokine levels were related to serum and urinary biomarkers
of cartilage and synovial metabolism as well as radiographic OA burden
and 5-year progression
Baseline plasma leptin, adiponectin, and resistin levels were assessed by
ELISA in samples from CHECK (Cohort Hip & Cohort Knee), a prospective
cohort of 1002 individuals with symptoms of (very) early knee and/or hip
OA.
Baseline biomarkers of cartilage and synovial metabolism were assessed
by ELISA or RIA (Cartilage: uCTX-II, sPIIANP, sCS846. Synovial tissue: sHA,
sPIIINP. Cartilage/synovial tissue: sCOMP).
Knee and hip radiographs were obtained at baseline and after 2 and 5
years. OA burdenwas expressed as the summed Kellgren & Lawrence (K&L)
score for knees and hips at baseline. OA progression was expressed as the
area under the curve (AUC) of the summed K&L scores.
Associations were investigated through multiple linear regression and
binary logistic regression (OA burden: summed K&L grade 0 vs >1,
progression: AUC 0 vs >0).
Results: Data were complete for approximately 800 participants at base-
line and 725 participants at all time points. Baseline summed K&L grades 0,
1, 2, 3, and 4 were present in 33.9, 26.8, 24.0, 9.6, and 5.7% of participants,
respectively (maximum K&L grade for individual joints¼1). AUC of
